Treatment with the chimeric anti-IL-2Rα basiliximab affects both the IL-2 and IL-15 signalling pathways after clinical kidney transplantation

2001-04-05

Transplantation Proceedings , Volume 33 - Issue 1-2 p. 1007- 1008

Additional Metadata
Persistent URL	doi.org/10.1016/S0041-1345(00)02306-X, hdl.handle.net/1765/52484
Journal	Transplantation Proceedings
Organisation	Department of Internal Medicine
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Boelaars-van Haperen, M. J. A. M., Baan, C., van Riemsdijk, I., IJzermans, J.& Weimar, W. (2001). Treatment with the chimeric anti-IL-2Rα basiliximab affects both the IL-2 and IL-15 signalling pathways after clinical kidney transplantation. Transplantation Proceedings, 33(1-2), 1007–1008.https://doi.org/10.1016/S0041-1345(00)02306-X

Publication